135 related articles for article (PubMed ID: 10073910)
1. Genotyping of a case of tyrosinaemia type I with normal level of succinylacetone in amniotic fluid.
Poudrier J; Lettre F; St-Louis M; Tanguay RM
Prenat Diagn; 1999 Jan; 19(1):61-3. PubMed ID: 10073910
[TBL] [Abstract][Full Text] [Related]
2. A case of tyrosinaemia type I with normal level of succinylacetone in the amniotic fluid.
Grenier A; Cederbaum S; Laberge C; Gagné R; Jakobs C; Tanguay RM
Prenat Diagn; 1996 Mar; 16(3):239-42. PubMed ID: 8710777
[TBL] [Abstract][Full Text] [Related]
3. Prenatal diagnosis of hereditary tyrosinaemia: measurement of succinylacetone in amniotic fluid.
Gagné R; Lescault A; Grenier A; Laberge C; Mélançon SB; Dallaire L
Prenat Diagn; 1982 Jul; 2(3):185-8. PubMed ID: 7145846
[TBL] [Abstract][Full Text] [Related]
4. The antenatal diagnosis and aid to the management of hereditary tyrosinaemia by use of a specific and sensitive GC-MS assay for succinylacetone.
Pettit BR; MacKenzie F; King GS; Leonard JV
J Inherit Metab Dis; 1984; 7 Suppl 2():135-6. PubMed ID: 6434868
[No Abstract] [Full Text] [Related]
5. Neonatal and prenatal diagnosis of hereditary tyrosinaemia.
King GS; MacKenzie F; Pettit BR
Lancet; 1983 Jun; 1(8336):1279. PubMed ID: 6134070
[No Abstract] [Full Text] [Related]
6. First-trimester prenatal diagnosis of tyrosinemia type I by amniotic fluid succinylacetone determination.
Jakobs C; Stellaard F; Kvittingen EA; Henderson M; Lilford R
Prenat Diagn; 1990 Feb; 10(2):133-4. PubMed ID: 2343022
[No Abstract] [Full Text] [Related]
7. Chemical analysis of succinylacetone and 4-hydroxyphenyllactate in amniotic fluid using selective ion monitoring.
Jakobs C; Sweetman L; Nyhan WL
Prenat Diagn; 1984; 4(3):187-94. PubMed ID: 6463026
[TBL] [Abstract][Full Text] [Related]
8. Early prenatal diagnosis of hereditary tyrosinaemia.
Pettit BR; Kvittingen EA; Leonard JV
Lancet; 1985 May; 1(8436):1038. PubMed ID: 2859481
[No Abstract] [Full Text] [Related]
9. Prenatal diagnosis of hereditary tyrosinemia by determination of fumarylacetoacetase in cultured amniotic fluid cells.
Kvittingen EA; Steinmann B; Gitzelmann R; Leonard JV; Andria G; Børresen AL; Mossman J; Micara G; Lindblad B
Pediatr Res; 1985 Apr; 19(4):334-7. PubMed ID: 4000758
[TBL] [Abstract][Full Text] [Related]
10. The pre- and post-natal diagnosis of tyrosinemia type I and the detection of the carrier state by assay of fumarylacetoacetase.
Kvittingen EA; Brodtkorb E
Scand J Clin Lab Invest Suppl; 1986; 184():35-40. PubMed ID: 3473612
[TBL] [Abstract][Full Text] [Related]
11. Deficiency of fumarylacetoacetase in a patient with hereditary tyrosinemia.
Berger R; Smit GP; Stoker-de Vries SA; Duran M; Ketting D; Wadman SK
Clin Chim Acta; 1981 Jul; 114(1):37-44. PubMed ID: 7249373
[TBL] [Abstract][Full Text] [Related]
12. Concentrations of succinylacetone after homogentisate and tyrosine loading in healthy individuals with low fumarylacetoacetase activity.
Kvittingen EA; Leonard JV; Pettit BR; King GS
Clin Chim Acta; 1985 Nov; 152(3):271-9. PubMed ID: 4064334
[TBL] [Abstract][Full Text] [Related]
13. Tyrosinaemia type I--an update.
Kvittingen EA
J Inherit Metab Dis; 1991; 14(4):554-62. PubMed ID: 1749221
[TBL] [Abstract][Full Text] [Related]
14. Possibilities for treatment and for early prenatal diagnosis of hereditary tyrosinaemia.
Holme E; Lindblad B; Lindstedt S
Lancet; 1985 Mar; 1(8427):527. PubMed ID: 2857895
[No Abstract] [Full Text] [Related]
15. Frequency of the IVS12 + 5G-->A splice mutation of the fumarylacetoacetate hydrolase gene in carriers of hereditary tyrosinaemia in the French Canadian population of Saguenay-Lac-St-Jean.
Poudrier J; St-Louis M; Lettre F; Gibson K; Prévost C; Larochelle J; Tanguay RM
Prenat Diagn; 1996 Jan; 16(1):59-64. PubMed ID: 8821854
[TBL] [Abstract][Full Text] [Related]
16. Stable isotope dilution analysis of succinylacetone using electron capture negative ion mass fragmentography: an accurate approach to the pre- and neonatal diagnosis of hereditary tyrosinemia type I.
Jakobs C; Dorland L; Wikkerink B; Kok RM; de Jong AP; Wadman SK
Clin Chim Acta; 1988 Feb; 171(2-3):223-31. PubMed ID: 3286060
[TBL] [Abstract][Full Text] [Related]
17. Hereditary tyrosinemia type I--an overview.
Kvittingen EA
Scand J Clin Lab Invest Suppl; 1986; 184():27-34. PubMed ID: 3296130
[TBL] [Abstract][Full Text] [Related]
18. Tyrosinaemia type Ia without excess of urinary succinylacetone.
Biasucci G; Giuffré B; La Grutta S; Riva E
J Inherit Metab Dis; 1993; 16(6):1056-7. PubMed ID: 8127063
[No Abstract] [Full Text] [Related]
19. Mutation analysis for prenatal diagnosis of hereditary tyrosinaemia type 1.
Mustonen A; Ploos van Amstel HK; Berger R; Salo MK; Viinikka L; Simola KO
Prenat Diagn; 1997 Oct; 17(10):964-6. PubMed ID: 9358577
[TBL] [Abstract][Full Text] [Related]
20. Dietary treatment eliminates succinylacetone from the urine of a patient with tyrosinaemia type 1.
Bain MD; Purkiss P; Jones M; Bingham P; Stacey TE; Chalmers RA
Eur J Pediatr; 1990 Jun; 149(9):637-9. PubMed ID: 2373116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
